Epilepsy affects approximately 50 million people worldwide, making it one of the most prevalent neurological diseases. However, up to 40% of individuals with epilepsy do not respond well to traditional anti-seizure medications, leading to drug-resistant epilepsy.

This video introduces the ketogenic diet therapy as an alternative management approach for drug-resistant epilepsy. The ketogenic diet is a high-fat, low-carbohydrate, adequate-protein diet that has shown promising results in reducing seizures. Individuals with diverse syndromes, such as infantile spasms, Dravet syndrome, Angelman syndrome, and others, may benefit from ketogenic diet therapy.

By exploring the challenges of drug-resistant epilepsy and the potential of ketogenic diet therapy, this video provides educational insights into alternative treatment options for those with epilepsy. For more information about the use of ketogenic diet therapy for drug-resistant epilepsy, viewers are encouraged to visit matthewsfriends.org and neuroketo.org.